Medical College of Wisconsin
HomeMilestonesSite MapContact Us  

Components

Technology Development

 

Animal Models

 

Protein Analysis

 

Bioinformatics

   
 
 

PepID

 

DeNovoID

 

ProMoST

 

ZoomQuant

 

BioMart

 

Apropos

   
 
 

Overview

 

Components

 

Resources

 

Milestones

 

Site Map

 

Contact Us

   
 
 

Bioinformatics

 

HMGC home

 

BBC home

 

MCW home

 

NHLBI Proteomics

 

NHLBI home

   

You are visiting: Home > Components > Component: Protein Analysis

Component: Protein Analysis and Technology Implementation

Component Protein Analysis and Technology Implementation focuses on development of protein separation techniques, implementation of new MS technologies, analysis of consomic samples.

Please choose the folowing items to find more information about this component.
 

Methods and Results

Component Members

Data Reports

 

Goals and Milestones

One of the major goals of the MCW Proteomics Center is to develop new strategies and methods for the separation and isolation of different classes of proteins from cellular lysates. These methods will serve as a preliminary step to mass spectrometric characterization of the proteome or sub-proteomes of mammalian cells.

Initially, our component will focus on:

  1. Development of ELISA methods to quantify five different proteins known to be involved in angiogenesis:
      a. Vascular Endothelial Growth Factor (VEGF)
      b. Vascular Endothelial Growth Factor Receptor1 (VEGF-R1)
      c. Vascular Endothelial Growth Factor Receptor2 (VEGF-R2)
      d. Osteopontin (OSTP)
      e. Endothelial Nitric-Oxide Synthase (eNOS)
  2. Protocols for immunoprecipitation of individual proteins
  3. Methods for efficient isolation of all proteins, membrane-bound proteins, or phosphoproteins from cells
  4. Development of mass-spectrometric methods to identify, characterize, and quantify proteins from simple and complex protein mixtures. Special emphasis will be given to the analysis of posttranslational modifications of proteins.

Component 2 will provide rat endothelial cells (rVEC) for these studies. Cells will be obtained by rat hind limb dissection from both parental rat strains and consomic animals. Cells will undergo angiogenic stimuli in vivo or in vitro, and will be tested using assays and protocols developed by our component. Protocols and assays will be developed and distributed in collaboration with Pierce Milwaukee, a division of Perbio Sciences AB.

 

 

[ back to top ]